|
Market Closed -
Nasdaq
16:00:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 3.800 USD | +1.06% |
|
+0.80% | +1.60% |
| 08-06 | SAB Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-29 | SAB Biotherapeutics, Inc.(NasdaqCM:SABS) added to Russell 2000 Index | CI |
| Market Cap | 346M 300M 281M 256M 481M 32.98B 489M 3.3B 1.29B 16.51B 1.3B 1.27B 55.06B | P/E 2026 * |
-3.7x | P/E 2027 * | -4.91x |
|---|---|---|---|---|---|
| Enterprise Value | 91.02M 78.86M 73.89M 67.39M 127M 8.68B 129M 869M 340M 4.35B 342M 334M 14.49B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 1,104x |
| Free-Float |
99.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SAB Biotherapeutics, Inc.
| 1 day | +1.06% | ||
| 1 week | +0.80% | ||
| Current month | +6.44% | ||
| 1 month | -0.52% | ||
| 3 months | +4.97% | ||
| 6 months | -7.77% | ||
| Current year | +1.60% |
| 1 week | 3.67 |  | 3.95 |
| 1 month | 3.35 | | 3.97 |
| Current year | 3.28 | | 5.15 |
| 1 year | 1.85 | | 5.15 |
| 3 years | 1 | | 10.5 |
| 5 years | 1 | | 129 |
| 10 years | 1 | | 129 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eddie Sullivan
CEO | Chief Executive Officer | 60 | 2014-06-30 |
Samuel Reich
CEO | Chief Executive Officer | 51 | 2024-02-01 |
Lucy To
DFI | Director of Finance/CFO | 40 | 2024-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Reich
CHM | Chairman | 51 | 2021-10-21 |
William Polvino
BRD | Director/Board Member | 65 | 2019-10-21 |
David Link
BRD | Director/Board Member | 70 | 2021-10-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/5/26 | Free | Chief Executive Officer | 4,800,000 | 10.0826% | ||
| 2/3/26 | Free | Founder | 3,000,000 | 6.3016% | ||
| 2/3/26 | Free | Chief Technology Officer | 2,400,000 | 5.0413% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | +0.80% | +75.93% | -50.60% | 342M | |
| -0.73% | +7.82% | +73.81% | +102.34% | 70.51B | |
| +1.60% | +1.66% | +37.76% | +67.36% | 54.05B | |
| -0.22% | +33.59% | +8.43% | +489.75% | 28.95B | |
| +1.36% | +10.63% | +48.64% | +7.59% | 24.05B | |
| -0.06% | +0.61% | -16.45% | -13.26% | 23.31B | |
| -1.37% | +7.87% | +251.71% | +464.53% | 18.67B | |
| +2.21% | +7.66% | +47.18% | -20.09% | 18.37B | |
| +0.66% | +4.43% | +26.79% | +626.71% | 16.1B | |
| -1.85% | -11.15% | +32.75% | +134.11% | 12.72B | |
| Average | +0.12% | +7.80% | +58.66% | +180.84% | 26.71B | |
| Weighted average by Cap. | +0.11% | +9.57% | +55.10% | +168.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 62.5K 54.15K 50.74K 46.28K 87K 5.96M 88.34K 597K 233K 2.98M 235K 230K 9.95M |
| Net income | -85.34M -73.94M -69.27M -63.18M -119M -8.14B -121M -815M -318M -4.08B -320M -313M -13.59B | -102M -87.96M -82.42M -75.17M -141M -9.68B -143M -969M -379M -4.85B -381M -373M -16.17B |
| Net Debt | -255M -221M -207M -189M -355M -24.3B -360M -2.43B -951M -12.17B -956M -936M -40.56B | -277M -240M -225M -205M -385M -26.4B -391M -2.64B -1.03B -13.22B -1.04B -1.02B -44.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | US$3.800 | +1.06% | 307,681 |
| 26-08-11 | US$3.760 | -0.53% | 312,037 |
| 26-08-10 | US$3.780 | -3.08% | 297,355 |
| 26-08-07 | US$3.900 | +1.30% | 343,907 |
| 26-08-06 | US$3.850 | +2.12% | 280,361 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SABS Stock
Select your edition
All financial news and data tailored to specific country editions
